ADC Therapeutics SA Revenue 2019-2023 | ADCT
ADC Therapeutics SA revenue from 2019 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
ADC Therapeutics SA Annual Revenue
(Millions of US $) |
| 2022 |
$210 |
| 2021 |
$34 |
| 2020 |
$ |
| 2019 |
$2 |
| 2018 |
$1 |
ADC Therapeutics SA Quarterly Revenue
(Millions of US $) |
| 2023-03-31 |
$19 |
| 2022-12-31 |
$70 |
| 2022-09-30 |
$76 |
| 2022-06-30 |
$17 |
| 2022-03-31 |
$46 |
| 2021-12-31 |
$17 |
| 2021-09-30 |
$13 |
| 2021-06-30 |
$4 |
| 2021-03-31 |
|
| 2020-12-31 |
|
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
|
| 2019-09-30 |
|
| 2019-06-30 |
$2 |
| 2018-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.183B |
$0.210B |
|
ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.
|
